- Report
- November 2024
- 150 Pages
Global
From €4784EUR$4,850USD£3,986GBP
- Report
- May 2024
- 185 Pages
Global
From €4439EUR$4,500USD£3,699GBP
- Report
- May 2024
- 131 Pages
Global
From €6411EUR$6,499USD£5,342GBP
- Report
- May 2024
- 135 Pages
Global
From €6411EUR$6,499USD£5,342GBP
- Report
- May 2024
- 131 Pages
Global
From €6411EUR$6,499USD£5,342GBP
- Report
- May 2024
- 140 Pages
Global
From €6411EUR$6,499USD£5,342GBP
- Report
- May 2024
- 137 Pages
Global
From €6411EUR$6,499USD£5,342GBP
- Report
- May 2024
- 138 Pages
Global
From €6411EUR$6,499USD£5,342GBP
- Report
- May 2024
- 132 Pages
Global
From €6411EUR$6,499USD£5,342GBP
- Report
- May 2024
- 130 Pages
Global
From €6411EUR$6,499USD£5,342GBP
- Report
- May 2024
- 128 Pages
Global
From €6411EUR$6,499USD£5,342GBP
- Report
- May 2024
- 135 Pages
Global
From €6411EUR$6,499USD£5,342GBP
- Report
- May 2024
- 130 Pages
Global
From €6411EUR$6,499USD£5,342GBP
- Report
- May 2024
- 140 Pages
Global
From €6411EUR$6,499USD£5,342GBP
- Report
- May 2024
- 138 Pages
Global
From €6411EUR$6,499USD£5,342GBP
- Report
- May 2024
- 133 Pages
Global
From €6411EUR$6,499USD£5,342GBP
- Report
- May 2024
- 140 Pages
Global
From €6411EUR$6,499USD£5,342GBP
- Report
- August 2024
- 136 Pages
Global
From €2958EUR$2,999USD£2,465GBP
- Report
- August 2024
- 144 Pages
Global
From €2958EUR$2,999USD£2,465GBP
- Drug Pipelines
- June 2024
- 180 Pages
Global
From €2466EUR$2,500USD£2,055GBP

The Skin Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat skin cancer. These drugs are used to treat a variety of skin cancer types, including melanoma, basal cell carcinoma, and squamous cell carcinoma. The drugs are typically administered orally, intravenously, or topically.
The market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Novartis, Pfizer, and Roche. These companies are constantly researching and developing new treatments to improve the efficacy of existing treatments and to develop new treatments for skin cancer.
In addition to the major players, there are also many smaller companies that are developing treatments for skin cancer. These companies are often focused on developing treatments for rarer forms of skin cancer, such as Merkel cell carcinoma. Examples of these companies include Aduro Biotech, Arcutis Biotherapeutics, and OncoSec Medical. Show Less Read more